Related Experiment Videos
Structure, function, and immunogenicity of human insulinoma cells.
C H Thivolet1, A Demidem, M Haftek
1Institut National de la Santé et de la Recherche Medicale (INSERM), U34, Hôpital Debrousse, Lyon, France.
Diabetes
|September 1, 1988
Summary
Cultured human insulinoma cells retain insulin secretion capabilities and lose immune stimulatory properties over time. This suggests that removing contaminating non-islet cells promotes immune tolerance in vitro.
Area of Science:
- Endocrinology
- Immunology
- Cell Biology
Background:
- Human insulinoma cells are crucial for studying insulin secretion and diabetes.
- Understanding the immune interactions of insulinoma cells is vital for transplantation and therapy.
Purpose of the Study:
- To characterize the functional and immunological properties of human insulinoma cells in long-term culture.
- To investigate the impact of cell culture on insulinoma cell immunogenicity.
Main Methods:
- Human insulinoma cells were cultured for one month, undergoing three passages.
- Insulin and C-peptide release were measured under various stimulation conditions (glucose, IBMX, tolbutamide, glucagon, isoproterenol).
- Immunofluorescence and mixed lymphocyte reactions were used to assess cell surface markers and immune stimulatory capacity.
Main Results:
- Cultured insulinoma cells exhibited epithelial features and secreted insulin and C-peptide equimolarly.
- Cells responded to secretagogues, demonstrating preserved functionality.
- Crude insulinoma cells stimulated T-lymphocyte proliferation, but this response diminished significantly after one month in culture.
- Class I MHC molecules were expressed, but class II MHC molecules were absent in long-term cultures, unlike crude preparations.
Conclusions:
- Long-term culture of human insulinoma cells preserves their secretory function while reducing their immunogenicity.
- The loss of class II-positive contaminating cells during culture appears to induce immune tolerance.
- These findings have implications for the use of insulinoma cells in research and potential therapeutic applications.